Amcor, a global leader in responsible packaging solutions, will present its latest innovations at CPHI Frankfurt 2025, taking place from October 28–30.

The company will highlight its extensive portfolio of rigid and flexible packaging solutions designed to meet the diverse needs of patients and healthcare providers across categories such as consumer health, inhalation, injectables, dermal and body care, ophthalmic and nasal, ear and throat sprays, and drug delivery devices. 

A key highlight will be ClariPPil, a clarified polypropylene (PP) alternative to standard PET jars for pills and tablets. According to Amcor, ClariPPil offers enhanced moisture protection, strong product integrity and recyclability in countries with appropriate infrastructure.

Another featured innovation is Amcor’s 10 ml easy-squeeze ophthalmic bottle, now qualified for use with Aptar Pharma’s Ophthalmic Squeeze Dispenser (OSD) – a leading preservative-free solution for prescription and OTC eye treatments such as conjunctivitis and glaucoma.

Also, on display will be RS01X, the digitally connected version of Amcor’s RS01 single-dose Dry Powder Inhaler (DPI).

From its flexible packaging portfolio, Amcor will showcase AmSky, a breakthrough, mono-PE, aluminum and PVC-free, PFAS-compliant thermoform blister system.

The company will also showcase its High Shield Pharma Laminates, offering advanced barrier protection for pharmaceutical products in sachet, stickpack, and strippack formats.

Moreover, Amcor will present its fully integrated Contract Development and Manufacturing Organization (CDMO) services, offering end-to-end support from product conceptualization through to manufacturing and final packaging.

“CPHI remains a key event for connecting pharmaceutical professionals with the latest innovations in packaging and drug delivery,” said Virginie Maes, VP healthcare for Amcor Flexibles.

“We’re looking forward to showcasing our comprehensive portfolio, including ClariPPil jars and OSD bottles for oral solid dose applications, alongside our flexible solutions such as AmSky and high-shield pharma laminates. These offerings reflect our commitment to sustainability, patient-centric design, and versatility – addressing key industry challenges while enhancing both product protection and user experience,” she added.